Results 181 to 190 of about 48,215 (217)

Optimal Duration of Adjuvant Platinum-Etoposide in High-Risk Merkel Cell Carcinoma. [PDF]

Medicina (Kaunas)
Brenner R, Edri HTF, Rouvinov K, Shani Shrem N, Meirovitz A, El-Saied S, Berezhnov I, Ievko A, Turaieva S, Fenig S, Abu Yasin N, Fenig E, Hussany S, Yakobson A, Shalata W.   +14 more
europepmc   +1 more source

Value-based pricing of tislelizumab plus chemotherapy versus chemotherapy alone for advanced oesophageal squamous cell carcinoma: a Markov modelling study from the US payer perspective. [PDF]

BMJ Open
Abdeen AA, Ayer T, Lim F, Shue S, Hur C.
europepmc   +1 more source

Venetoclax combined with chidamide and decitabine successfully induced remission in relapsed/refractory classical Hodgkin lymphoma: a case report and literature review. [PDF]

Front Immunol
Jin X, Tang Y, Wu Y, Ji J.
europepmc   +1 more source